Company Name:Athenex Inc.
CEO: Johnson Y.N. Lau

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Athenex Inc is a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer.


Key numbers

Market Capitalization:901394780
Shares Outstanding: 77506000
Float: 58474324.194
Next Earning Date:2020-03-30
TTm EPS: -1.8182
TTm Dividend Rate:
200 days moving average:13.94
50 days moving average: 12.07
One day percent Change: 1.51



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,